NCT02485600 Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients Status COMPLETED Phase N/A
NCT02483104 Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02478320 Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors Status TERMINATED Phase PHASE2
NCT02476617 Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults Status COMPLETED Phase PHASE3
NCT02471118 Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA) Status COMPLETED Phase PHASE2
NCT02470585 Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status TERMINATED Phase PHASE3
NCT02462525 Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02461745 Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO Status COMPLETED Phase PHASE4
NCT02451839 An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) Status COMPLETED Phase N/A
NCT02446717 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy Status COMPLETED Phase PHASE2/PHASE3
NCT02443298 Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma Status COMPLETED Phase PHASE2
NCT02442284 A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection Status COMPLETED Phase PHASE3
NCT02442271 A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil Status COMPLETED Phase PHASE3
NCT02442258 Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02441283 A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530 Status COMPLETED Phase PHASE2/PHASE3
NCT02433340 Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study Status COMPLETED Phase PHASE2
NCT02429895 A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Status TERMINATED Phase PHASE2
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT02414633 Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]) Status COMPLETED Phase N/A